U.S. Markets open in 8 hrs 40 mins

PDL BioPharma, Inc. (PDLI) Jumps: Stock Rises 8.2%

Zacks Equity Research

PDL BioPharma, Inc. PDLI was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.79 to $3.03 in the past one-month time frame.

The company has seen one negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

PDL BioPharma currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

PDL BioPharma, Inc. Price

PDL BioPharma, Inc. Price | PDL BioPharma, Inc. Quote

Another stock worth considering in the Medical sector is Protagonist Therapeutics, Inc. PTGX which carries a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PDLI going up? Or down? Predict to see what others think: Up or Down.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PDL BioPharma, Inc. (PDLI) : Free Stock Analysis Report
 
Protagonist Therapeutics, Inc. (PTGX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research